NCT03864666 - Bioequivalence Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 11, 2019

Primary Completion Date

March 19, 2019

Study Completion Date

May 3, 2019

Conditions

Intermittent Claudication

Interventions

DRUG

Cilostazol 100 mg

One Cilostazol 100 mg at 08:00 and another at 20:00, two oral doses (total daily dose of 200 mg)

DRUG

PMR 200 mg

Two PMR 200 mg at 08:00, single oral dose (total daily dose of 400 mg)

Trial Locations (1)

Bio-Kinetic Clinical Applications, LLC, Springfield